Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes

    ... human leukocyte antigen -identical sibling or match unrelated donor options. A preemptive management approach to patients at high risk ...

    Research Article last updated 09/24/2014 - 10:46am.

  2. The diagnosis and treatment of aplastic anemia: a review

    ... therapy for patients <40 years when a matched sibling donor (MSD) is not available for transplant. MSD hematopoietic stem cell ... but a response rate of about 60 %. Front-line matched unrelated donor (MUD) appears to be a viable option in children with ...

    Research Article last updated 05/26/2015 - 10:30am.

  3. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)

    ... stem cell transplant (HSCT) from a matched sibling donor (MSD) is the treatment of choice. If a MSD is not available, the options include immunosuppressive therapy (IST) or unrelated donor HSCT. The objective of this guideline is to provide ...

    Research Article last updated 05/27/2015 - 1:21pm.

  4. Finding a Stem Cell Donor

    ... When should I start looking for a suitable donor? If your doctor thinks you may be a candidate for a bone marrow ... donor . And it can take a long time to find a matched unrelated donor if no related donor is available. How does the search ...

    Page last updated 05/14/2015 - 9:46am.

  5. Non-myeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia

    ... aplastic anemia (SAA) who lack a matched sibling or unrelated donor (UD) or who have failed UD or cord blood transplant . ...

    Research Article last updated 08/04/2014 - 8:20am.

  6. Timing of allogeneic stem cell transplantation for myelodysplastic syndromes and aplastic anemia

    ... than 25% of newly diagnosed patients. The use of early unrelated donor HSCT is an evolving concept that will become more accepted as ...

    Research Article last updated 03/03/2015 - 1:26pm.

  7. Timing of allogeneic stem cell transplantation for myelodysplastic syndromes and aplastic anemia

    ... than 25% of newly diagnosed patients. The use of early unrelated donor HSCT is an evolving concept that will become more accepted as ...

    Research Article last updated 03/03/2015 - 11:22am.

  8. Haploidentical transplantation in patients with acquired aplastic anemia

    ... and lacking an HLA -matched related or unrelated donor . The platforms of both ex vivo T-cell-depleted and unmanipulated ...

    Research Article last updated 02/04/2013 - 2:16pm.

  9. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... patients with hematologic malignancies undergoing unrelated donor peripheral blood stem cell transplant . Giving chemotherapy and total-body irradiation before a donor peripheral blood stem cell transplant (PBSCT) helps stop the growth of ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  10. Myelodysplastic syndromes: who and when in the course of disease to transplant

    ... disease-free survival. In recent years, alternative donor sources have been demonstrated to be a viable alternative to traditional sibling and matched unrelated donor stem cell sources. Efforts at transplantation regimen ...

    Research Article last updated 01/02/2013 - 3:02pm.